Search
Biodesix Inc
BDSXAdd to Watchlist
16.820USD
+1.600+10.51%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
138.82MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-17The current earnings forecast score of Biodesix Inc is 8.40, ranking 18 out of 76 in the Healthcare Providers & Services industry. The average price target is 35.00, with a high of 40.00 and a low of 20.00.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
26.000
Target Price
+66.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Biodesix Inc
BDSX
6
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Tenet Healthcare Corp
THC
23
Natera Inc
NTRA
21
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Biodesix Inc's expected revenue for the next quarter?
Biodesix Inc's expected revenue is 25.96M.
What is Biodesix Inc's price target?
Analysts forecast that Biodesix Inc's price target is USD 35.00, with the highest forecast at USD 40.00 and the lowest forecast at USD 20.00.
How have Biodesix IncBDSX's recent earnings per share performed?
The market expectation was USD -0.81, while Biodesix IncBDSX's earnings per share (EPS) for the previous quarter was USD -0.49. EPS for the next quarter is expected at USD -0.90.
What is the analyst rating for Biodesix Inc?
Based on the ratings of Biodesix Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
